BioNTech SE
NASDAQ:BNTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
Audax Renovables SA
MAD:ADX
|
ES |
|
Phunware Inc
NASDAQ:PHUN
|
US |
|
N
|
NOS SGPS SA
ELI:NOS
|
PT |
|
I
|
Iss A/S
XMUN:QJQ
|
DK |
|
N
|
Nedbank Group Ltd
JSE:NED
|
ZA |
|
A
|
ASN Broker PCL
SET:ASN
|
TH |
|
C
|
CAE Inc
NYSE:CAE
|
CA |
|
C
|
Compal Electronics Inc
TWSE:2324
|
TW |
|
P
|
Philip Morris International Inc
SIX:PMI
|
US |
|
Amphenol Corp
NYSE:APH
|
US |
|
D
|
Diageo PLC
OTC:DGEAF
|
UK |
|
S
|
Serta Simmons Bedding LLC
NASDAQ:SRTA
|
US |
|
Synopsys Inc
MIL:1SNPS
|
US |
|
Reliance Steel & Aluminum Co
NYSE:RS
|
US |
|
S
|
Stainless Tankers ASA
F:ZC0
|
NO |
|
Pebble Group PLC
LSE:PEBB
|
UK |
|
A
|
Arctic Paper SA
WSE:ATC
|
PL |
|
D
|
Dimand Societe Anonyme for The Use and Construction of Real Estate Constructions Services and Participations
ATHEX:DIMAND
|
GR |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
Danaos Corp
NYSE:DAC
|
GR |
|
S
|
Swire Pacific Ltd
F:SWI
|
HK |
|
Enterprise Products Partners LP
NYSE:EPD
|
US |
|
C
|
Chrysos Corp Ltd
ASX:C79
|
AU |
Bankruptcy Probability
BioNTech SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioNTech SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
23.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioNTech SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioNTech SE has total debt of 246.1m EUR. This includes both short-term (0 EUR) and long-term (246.1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
